Research Article

Modeling Drug-Carrier Interaction in the Drug Release from Nanocarriers

Figure 3

The model fit into release data. (a) Carboxylfluorescein from thermosensitive liposomes with different PEG addition [24]. (b, c) Verapamil and doxorubicin from liposomes [25]. (d) Amiodarone from LNC [26]. (e) BSA from PLLA nanocapsules [29]. (f) Indomethacin from PECL nanocapsules [27]. Solid lines represent the model prediction.
370308.fig.003a
(a)
370308.fig.003b
(b)
370308.fig.003c
(c)
370308.fig.003d
(d)
370308.fig.003e
(e)
370308.fig.003f
(f)